Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$596.92 USD

596.92
2,138,161

+3.13 (0.53%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Cardiovascular Systems (CSII) Loss Wider Than Estimates in Q1

We are upbeat about the year-over-year uptick in both Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.

Accuray (ARAY) Q1 Wider Than Expected, FY20 View Retained

Accuray (ARAY) reiterates revenue and adjusted EBITDA view for fiscal 2020.

Ecolab (ECL) Earnings and Revenues Miss Estimates in Q3

Global Industrial unit aid Ecolab's (ECL) Q3 results; 2019 EPS view slashed.

Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Walgreens Boots (WBA) Q4 Earnings Surpass, Margins Fall

Growth within the Retail Pharmacy USA and Pharmaceutical Wholesale divisions of Walgreens Boots (WBA) is partially offset by a dull performance at Retail Pharmacy International.

Omnicell (OMCL) Beats on Q3 Earnings, Raises '19 EPS View

Omnicell (OMCL) continues to see solid segmental contributions in Q3. Expansion of gross and operating margins is a positive too.

Cerner (CERN) Earnings Beat Estimates in Q3, Improve Y/Y

Cerner (CERN) Q3 results benefit from higher revenues, gains in Licensed software, Technology resale, Professional and Managed services units, and international revenue growth.

NextGen (NXGN) Q2 Earnings Beat, Revenues Miss Estimates

NextGen (NXGN) retains its fiscal 2020 revenue and EPS guidance.

GNC Holdings (GNC) Q3 Loss Meets Estimates, Revenues Miss

GNC Holdings' (GNC) third-quarter 2019 results, reflecting dismal performance across segments, disappoint investors.

TMO vs. EW: Which Stock Is the Better Value Option?

TMO vs. EW: Which Stock Is the Better Value Option?

Illumina (ILMN) Beats Q3 Earnings Estimates, Raises View

Illumina (ILMN) announces impressive Q3 results on the back of strong growth in the sequencing business.

Company News For Oct 24, 2019

Companies In The News Are: ALXN,ANTM,TMO,BSX

Thermo Fisher (TMO) Beats on Q3 Earnings, Lifts Guidance

We are encouraged that three out of Thermo Fisher's (TMO) four business segments have registered strong year-over-year revenue growth in Q3.

Thermo Fisher Scientific (TMO) Q3 Earnings and Revenues Top Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 2.08% and 1.33%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Medical Products' Earnings Roster for Oct 23: TMO, BSX & More

Encouraging growth in the emerging markets despite the ongoing trade tiff is likely to contribute to revenues in the medical products space this earnings season.

What's in Store for Thermo Fisher (TMO) in Q3 Earnings?

Developments in business segments are likely to have aided Thermo Fisher (TMO) in the third quarter.

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?

Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Urmimala Biswas headshot

Thermo Fisher Gets a Boost from Buyouts and Global Expansion

Thermo Fisher (TMO) registers a solid international performance with strong growth in Europe and Asia-Pacific including China.

The Zacks Analyst Blog Highlights: Microsoft, Royal Dutch, IBM, Thermo Fisher and American Tower

The Zacks Analyst Blog Highlights: Microsoft, Royal Dutch, IBM, Thermo Fisher and American Tower

Mark Vickery headshot

Top Stock Reports for Microsoft, Royal Dutch Shell & IBM

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Royal Dutch Shell (RDS.A) and IBM (IBM).

Thermo Fisher Closes API Site Buyout, Fortifies Pharma Unit

Following the acquisition closure of GlaxoSmithKline's plant, Thermo Fisher (TMO) will continue to manufacture APIs for the same under a multi-year supply agreement.

Here's Why You Should Add Thermo Fisher to Your Portfolio

Investors continue to be optimistic about Thermo Fisher's (TMO) performance.

Zacks.com featured highlights include: Booz Allen Hamilton, Thermo Fisher Scientific, Target, Microsoft and Barrel Old Country Store

Zacks.com featured highlights include: Booz Allen Hamilton, Thermo Fisher Scientific, Target, Microsoft and Barrel Old Country Store

Sweta Killa headshot

7 Dividend Growth Stocks to Buy for October

Dividend-paying securities are a major source of consistent income for investors when returns from the equity market are at risk.